My UM
My UM
Search

R.I.Y. Lieverse

Recent publications
  • Halilaj, I., Ankolekar, A., Lenaers, A., Chatterjee, A., Oberije, C. J. G., Eppings, L., Smit, H. J. M., Hendriks, L. E. L., Jochems, A., Lieverse, R. I. Y., van Timmeren, J. E., Wind, A., & Lambin, P. (2024). Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer. Frontiers in Digital Health, 5, Article 1303261. https://doi.org/10.3389/fdgth.2023.1303261
    More information about this publication
  • Van Limbergen, E. J., Hoeben, A., Lieverse, R. I. Y., Houben, R., Overhof, C., Postma, A., Zindler, J., Verhelst, F., Dubois, L. J., De Ruysscher, D., Troost, E. G. C., & Lambin, P. (2021). Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study. International Journal of Radiation Oncology Biology Physics, 109(5), 1421-1430. https://doi.org/10.1016/j.ijrobp.2020.11.053
    More information about this publication
  • Marcus, D., Lieverse, R. I. Y., Klein, C., Abdollahi, A., Lambin, P., Dubois, L. J., & Yaromina, A. (2021). Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. Cancers, 13(6), Article 1468. https://doi.org/10.3390/cancers13061468
    More information about this publication
  • Olivo Pimentel, V., Marcus, D., van der Wiel, A. M., Lieuwes, N. G., Biemans, R., Lieverse, R. I., Neri, D., Theys, J., Yaromina, A., Dubois, L. J., & Lambin, P. (2021). Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy. Journal for ImmunoTherapy of Cancer, 9(3), Article 001764. https://doi.org/10.1136/jitc-2020-001764
    More information about this publication
  • Lieverse, R. I. Y., Marcus, D., van der Wiel, A. M. A., Van Limbergen, E. J., Theys, J., Yaromina, A., Lambin, P., & Dubois, L. J. (2020). Human fibronectin extra domain B as a biomarker for targeted therapy in cancer. Molecular oncology, 14(7), 1555-1568. https://doi.org/10.1002/1878-0261.12705
    More information about this publication
  • Lieverse, R. I. Y., Van Limbergen, E. J., Oberije, C. J. G., Troost, E. G. C., Hadrup, S. R., Dingemans, A.-M. C., Hendriks, L. E. L., Eckert, F., Hiley, C., Dooms, C., Lievens, Y., de Jong, M. C., Bussink, J., Geets, X., Valentini, V., Elia, G., Neri, D., Billiet, C., Abdollahi, A., ... Lambin, P. (2020). Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial. BMC Cancer, 20(1), Article 557. https://doi.org/10.1186/s12885-020-07055-1
    More information about this publication
  • Sanduleanu, S., van der Wiel, A. M. A., Lieverse, R. I. Y., Marcus, D., Ibrahim, A., Primakov, S., Wu, G., Theys, J., Yaromina, A., Dubois, L. J., & Lambin, P. (2020). Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation Tracer. Cancers, 12(5), Article 1322. https://doi.org/10.3390/cancers12051322
    More information about this publication
  • Lambin, P., Lieverse, R. I. Y., Eckert, F., Marcus, D., Oberije, C., van der Wiel, A. M. A., Guha, C., Dubois, L. J., & Deasy, J. O. (2020). Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy. Seminars in Radiation Oncology, 30(2), 187-193. https://doi.org/10.1016/j.semradonc.2019.12.003
    More information about this publication
  • Rogers, W., Seetha, S. T., Refaee, T. A. G., Lieverse, R. I. Y., Granzier, R. W. Y., Ibrahim, A., Keek, S. A., Sanduleanu, S., Primakov, S. P., Beuque, M. P. L., Marcus, D., van der Wiel, A. M. A., Zerka, F., Oberije, C. J. G., van Timmeren, J. E., Woodruff, H. C., & Lambin, P. (2020). Radiomics: from qualitative to quantitative imaging. British Journal of Radiology, 93(1108), Article 20190948. https://doi.org/10.1259/bjr.20190948
    More information about this publication
  • Lambin, P., Lieverse, R., Baumann, M., & Ebert, N. (2019). Will immunotherapy really change radiotherapy? Lancet oncology, 20(12), 1642-1644. https://doi.org/10.1016/S1470-2045(19)30682-5
    More information about this publication
Go to all publications